Epidemiology of Schizophrenia in Bulgaria

AstraZeneca

Status: Completed

Conditions: Schizophrenia

Study type: Observational

Funder types: Industry

Identifiers

NCT00984373

NIS-NBG-SER-2009/1

Details and patient eligibility

About

The purpose of this study is to provide accurate, reliable information on schizophrenia clinical management in order to detect unmet medical needs of this disease in terms of:

• Patient characteristics.
• Diagnostic and treatment approaches: initial and subsequent.

Enrollment: 440 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with schizophrenia
• Above 18 years
• Signed Informed consent

Exclusion criteria

• Below 18 years
• Consent refused